Jean Bennett - 03 Sep 2021 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Issuer symbol
RGNX
Transactions as of
03 Sep 2021
Net transactions value
$0
Form type
4
Filing time
08 Sep 2021, 16:20:03 UTC
Next filing
07 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 03 Sep 2021 Common Stock 20,000 $34.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in equal monthly installments over the 36 months following September 3, 2021, with immediate full vesting in the event of a change in control.